Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Michelle Campbell a Office of the President, Medical Research Council
of Canada, 1600 Scott Street, Ottawa, Ontario, Canada K1 OW9, b Division of Public Health and Primary Health Care, Institute
of Health Sciences, University of Oxford, Oxford OX3 7LF, c Department of Primary Care and Population Sciences,
Royal Free and University College Medical School, London NW3 2PF, d General Practice and Primary Care Research Unit, Department of
Public Health and Primary Care, Institute of Public Health, Cambridge
CB2 2SR, e Neuroscience Trials Unit, Department of
Clinical Neurosciences, Western General Hospitals NHS Trust, Edinburgh
EH4 2XU, f MRC Biostatistics
Unit, Institute of Public Health, Cambridge CB2 2SR, g Department of Public
Mental Health, Imperial College of Science, Technology, and Medicine,
St Mary's Campus, London W2 1PD
Correspondence to:
R Fitzpatrick raymond.fitzpatrick@nuffield.ox.ac.uk
| The first 150 words of the full text of this article appear below. |
Randomised controlled trials are widely accepted as the
most reliable method of determining effectiveness, but most trials have
evaluated the effects of a single intervention such as a drug.
Recognition is increasing that other, non-pharmacological interventions
should also be rigorously evaluated.1-3 This paper examines the design and execution of research required to address the
additional problems resulting from evaluation of complex
interventions
that is, those "made up of various interconnecting
parts."4 The issues dealt with are discussed in a longer
Medical Research Council paper (www.mrc.ac.uk/complex_packages.html).
We focus on randomised trials but believe that this approach could be
adapted to other designs when they are more appropriate.
| Table Removed (Available Only in the Full Text) |
| |
Challenges of trials of complex interventions |
|---|
There are specific difficulties in defining, developing,
documenting, and reproducing complex interventions that are subject to
more variation than a drug. A typical example would be the design of a
trial to evaluate the benefits of specialist stroke units. Such a trial
Read all Rapid Responses